GenMark Diagnostics Inc (GNMK)

NASDAQ
24.04
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    24.03 - 24.06

GNMK Overview

Prev. Close
24.04
Day's Range
24.03-24.06
Revenue
171.56M
Open
24.04
52 wk Range
10.6-24.25
EPS
-0.28
Volume
0
Market Cap
1.77B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,336,708
P/E Ratio
-
Beta
3.02
1-Year Change
95.29%
Shares Outstanding
73,595,021
Next Earnings Date
Aug 03, 2021
What is your sentiment on GenMark Diagnostics Inc?
or
Market is currently closed. Voting is open during market hours.

GenMark Diagnostics Inc News

GenMark Diagnostics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuyStrong Buy
Technical IndicatorsBuyStrong SellBuyStrong Buy
SummaryStrong BuyNeutralBuyStrong Buy

GenMark Diagnostics Inc Company Profile

GenMark Diagnostics Inc Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Read More
  • Roche is buying out.
    0
    • is this max point of increase
      0
    • Dong ThreeThousand usually, when a buyout happens, the increase remains quite stable throughout the day. Cheers.
      0
  • anyone know what will happen now
    0
    • What happened?!!!!! Why???
      0
      • Frankfurt is up 15% for this stock!!
        0
        • I would imagine this gets higher than 12.33 in a week or two
          0
          • I guess nobody really cares about a brand new covid test. Not the catalyst lift i was hoping for. Sigh.
            0
            • Why the big down?
              0
              • Buy now?
                0
                • I hope you didn't do it in pre-market.
                  0
              • to late to buy?
                0
                • too late to buy?
                  0
                  • any body knows why GNMK is going down the last 2 days?
                    0
                    • yeah, it's weird, they had really positive 20Q1 published this week results, not sure what's going on
                      0
                    • Insider sale
                      0
                    • Most likely an effect of the public offering on May 11
                      0
                  • Buy and hold indeed, let's hope they get this out quick. It would be fantastic for everyone (myself included)
                    0
                    • Buy and hold
                      0
                      • hold tight, the moment it gets FDA approval you will not this price
                        0
                        • buy and hold
                          0
                          • why? any good news?!
                            0
                        • billion. and hold
                          0
                          • Sell while you can
                            0
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.